China Europe Fund Investment Director Gülen recently revealed the top ten major stocks, and the net worth growth rate of its sole management products in the third quarter surpassed the benchmark by a large margin. On October 27, the three quarterly reports of Gülen's managed products were disclosed. Currently, Gülen is managing 2 pharmaceutical-themed funds, namely China-Europe Healthcare and China-Europe Healthcare Innovation. Among them, the largest product is China-Europe Healthcare. The net asset value of the fund as of the end of the third quarter of 2026 was 25.544 billion yuan. In July 2025, China Europe Healthcare hired Zhao Lei as a fund manager to jointly manage the product with Gülen.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.